NO954389L - Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte - Google Patents

Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte

Info

Publication number
NO954389L
NO954389L NO954389A NO954389A NO954389L NO 954389 L NO954389 L NO 954389L NO 954389 A NO954389 A NO 954389A NO 954389 A NO954389 A NO 954389A NO 954389 L NO954389 L NO 954389L
Authority
NO
Norway
Prior art keywords
salt
squalene synthetase
synthetase inhibitor
phosphonosulfonate
inhibitor salts
Prior art date
Application number
NO954389A
Other languages
English (en)
Norwegian (no)
Other versions
NO954389D0 (no
Inventor
Yadagiri Pendri
Chung Pin Chen
David J Kucera
Eduardo J Martinez
Paul D Pansegrau
John K Thottathil
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO954389D0 publication Critical patent/NO954389D0/no
Publication of NO954389L publication Critical patent/NO954389L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075Esters with hydroxyalkyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
NO954389A 1994-11-03 1995-11-02 Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte NO954389L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33366194A 1994-11-03 1994-11-03

Publications (2)

Publication Number Publication Date
NO954389D0 NO954389D0 (no) 1995-11-02
NO954389L true NO954389L (no) 1996-05-06

Family

ID=23303735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954389A NO954389L (no) 1994-11-03 1995-11-02 Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte

Country Status (14)

Country Link
EP (1) EP0710665A1 (cs)
JP (1) JPH08208672A (cs)
KR (1) KR960017680A (cs)
CN (1) CN1130188A (cs)
AU (1) AU3458795A (cs)
CA (1) CA2159850A1 (cs)
CZ (1) CZ279595A3 (cs)
FI (1) FI955256L (cs)
HU (1) HUT73140A (cs)
IL (1) IL115537A0 (cs)
NO (1) NO954389L (cs)
PL (1) PL311218A1 (cs)
TW (1) TW318852B (cs)
ZA (1) ZA959326B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780974B1 (fr) * 1998-07-08 2001-09-28 Sod Conseils Rech Applic Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
CA2428669A1 (en) * 2000-11-09 2002-05-16 Takeda Chemical Industries, Ltd. High-density lipoprotein-cholesterol level elevating agent
CN101198252A (zh) 2005-04-18 2008-06-11 加利福尼亚大学董事会 用于细菌感染的抗微生物疗法
JP5161872B2 (ja) * 2006-05-12 2013-03-13 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア 細菌感染に対する抗微生物療法
CN101580472B (zh) * 2009-06-24 2013-07-10 广西壮族自治区化工研究院 1,1'-联-2-萘酚的拆分剂以及拆分方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ248852A (en) * 1992-10-28 1997-06-24 Squibb & Sons Inc Alpha-phosphono and phosphinosulphonates and medicaments thereof
US5312814A (en) * 1992-12-09 1994-05-17 Bristol-Myers Squibb Co. α-phosphonocarboxylate squalene synthetase inhibitors

Also Published As

Publication number Publication date
FI955256A7 (fi) 1996-05-04
PL311218A1 (en) 1996-05-13
AU3458795A (en) 1996-05-09
KR960017680A (ko) 1996-06-17
HUT73140A (en) 1996-06-28
EP0710665A1 (en) 1996-05-08
ZA959326B (en) 1997-05-05
CA2159850A1 (en) 1996-05-04
FI955256A0 (fi) 1995-11-02
FI955256L (fi) 1996-05-04
CN1130188A (zh) 1996-09-04
IL115537A0 (en) 1996-01-19
JPH08208672A (ja) 1996-08-13
NO954389D0 (no) 1995-11-02
CZ279595A3 (en) 1996-08-14
TW318852B (cs) 1997-11-01
HU9503136D0 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
WO1996040745A3 (en) Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
NO932620L (no) Amindiol-proteaseinhibitorer
GR3024133T3 (en) Isoxazoline compounds as antiinflammatory agents
HU9401571D0 (en) Saccharin derivative proteolytic enzyme inhibitors
CA2282654A1 (en) Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder
DK327689A (da) Diphosphonsyrederivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
ATE114661T1 (de) Benzylphosphonsäure-tyrosinkinaseinhibitoren.
SG52659A1 (en) Saccharin derivative proteolytic enzyme inhibitors
NO972043D0 (no) Tienopyridin eller tienopyrimidinderivater og deres anvendelse
MY112413A (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
AU2178895A (en) Heterocyclic-cyclic amine derivatives
GR3032506T3 (en) 3-aryl-2-isoxazolines as antiinflammatory agents
AU7107496A (en) Protein tyrosine kinase inhibitors for treating osteoarthritis
FI925756A0 (fi) Foerfarande foer rening av hyaluronsyra samt en ren hyaluronsyrafraktionavsedd foer oftalmisk anvaendning
AP9701007A0 (en) Substituted azetidin-2-ones for treatment of atherosclerosis.
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
MY116539A (en) New amino acid derivatives
AU5484996A (en) Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
BR9916272A (pt) 4 e 5-alquiniloxindóis e 4 e 5-alqueniloxindóis
CA2020858A1 (en) Water treatment agent and water treatment method for boiler
NO975878D0 (no) Framgangsmåte for behandling av avfallslam
NO954389L (no) Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte
MA23790A1 (fr) Procede pour desactiver ou detruire des microorganismes
AU2157500A (en) Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
NO982081L (no) Syntetiske mineralmikropartikler og retensjonshjelpemidler og vannbehandlingssystemer og fremgangsmÕter ved anvendelse av slike partikler